Impact of molecular testing on reported Clostridoides difficile infection rates.
Iulian IlieşJames C BenneyanTiago Barbieri Couto JaburArthur W BakerDeverick J AndersonPublished in: Infection control and hospital epidemiology (2019)
Hospitals that switched from EIA to NAAT testing experienced an average postswitch increase of 75% in reported CDI rates after adjusting for other factors, and this increase was often gradual or delayed.